Difference between revisions of "Section 1: Introduction (from DOI: 10.1186/s13054-020-02882-x) (Q10751)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: named entity (P78): Seizures (disease - MeSH descriptor) (Q11074), #quickstatements; #temporary_batch_1593005667867)
 
(8 intermediate revisions by the same user not shown)
Property / named entity
 +
Property / named entity: Consciousness Disorders (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Benzodiazepines (chemical - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Human (species) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: 2019 novel coronavirus (species) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Infections (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Critical Illness (disease - MeSH descriptor) / rank
 +
Normal rank
Property / Collection or Dataset of Origin
 +
Property / Collection or Dataset of Origin: Pubtator Central BioC-JSON formatted article files / rank
 +
Normal rank

Latest revision as of 23:02, 20 October 2020

Publication: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic"published as Crit Care; 2020 04 28 ; 24 (1) 176; DOI: 10.1186/s13054-020-02882-x
Language Label Description Also known as
English
Section 1: Introduction (from DOI: 10.1186/s13054-020-02882-x)
Publication: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic"published as Crit Care; 2020 04 28 ; 24 (1) 176; DOI: 10.1186/s13054-020-02882-x

    Statements

    0 references